Reich K, Lebwohl M, Paul C, Ropke M, Rosen M, Hansen K. Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.3];2(S1):S1. Available from: https://jofskin.org/index.php/skin/article/view/254